On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis

被引:92
作者
Hadinoto, Vey [1 ]
Shapiro, Michael [1 ]
Greenough, Thomas C. [2 ]
Sullivan, John L. [2 ]
Luzuriaga, Katherine [2 ]
Thorley-Lawson, David A. [1 ]
机构
[1] Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA
[2] Univ Massachusetts, Sch Med, Dept Pediat & Mol Med, Amherst, MA 01003 USA
关键词
D O I
10.1182/blood-2007-06-093278
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Memory B cells latently infected with Epstein-Barr virus (mB(Lats)) in the blood disappear rapidly on presentation with acute symptomatic primary infection (acute infectious mononucleosis [AIM]). They undergo a simple exponential decay (average half-life: 7.5 +/- 3.7 days) similar to that of normal memory B cells. The cytotoxic T lymphocyte (CTL) response to immediate early (IE) lytic antigens (CTLIEs) also decays over this time period, but no such correlation was observed for the CTL response to lytic or latent antigens or to the levels of virions shed into saliva. We have estimated the average half-life of CTLIEs to be 73 (+/- 23) days. We propose that cycles of infection and reactivation occur in the initial stages of infection that produce high levels of mB(Lats) in the circulation. Eventually the immune response arises and minimizes these cycles leaving the high levels of mB(Lats) in the blood to decay through simple memory B-cell homeostasis mechanisms. This triggers the cells to reactivate the virus whereupon most are killed by CTLIEs before they can release virus and infect new cells. The release of antigens caused by this large-scale destruction of infected cells may trigger the symptoms of AIM and be a cofactor in other AIM-associated diseases.
引用
收藏
页码:1420 / 1427
页数:8
相关论文
共 33 条
[1]
MORPHOLOGY, IMMUNOPHENOTYPE, AND DISTRIBUTION OF LATENTLY AND/OR PRODUCTIVELY EPSTEIN-BARR VIRUS-INFECTED CELLS IN ACUTE INFECTIOUS-MONONUCLEOSIS - IMPLICATIONS FOR THE INTERINDIVIDUAL INFECTION ROUTE OF EPSTEIN-BARR-VIRUS [J].
ANAGNOSTOPOULOS, I ;
HUMMEL, M ;
KRESCHEL, C ;
STEIN, H .
BLOOD, 1995, 85 (03) :744-750
[2]
The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell [J].
Babcock, GJ ;
Hochberg, D ;
Thorley-Lawson, DA .
IMMUNITY, 2000, 13 (04) :497-506
[3]
A prospective clinical study of Epstein-Barr virus and host interactions during acute infectious mononucleosis [J].
Balfour, HH ;
Holman, CJ ;
Hokanson, KM ;
Lelonek, MM ;
Giesbrecht, JE ;
White, DR ;
Schmeling, DO ;
Webb, CH ;
Cavert, W ;
Wang, DH ;
Brundage, RC .
JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (09) :1505-1512
[4]
Callan MFC, 1998, EUR J IMMUNOL, V28, P4382, DOI 10.1002/(SICI)1521-4141(199812)28:12<4382::AID-IMMU4382>3.0.CO
[5]
2-Z
[6]
Phenotypic and functional heterogeneity of EBV epitope-specific CD8+ T cells [J].
Catalina, MD ;
Sullivan, JL ;
Brody, RM ;
Luzuriaga, K .
JOURNAL OF IMMUNOLOGY, 2002, 168 (08) :4184-4191
[7]
Differential evolution and stability of epitope-specific CD8+ T cell responses in EBV infection [J].
Catalina, MD ;
Sullivan, JL ;
Bak, KR ;
Luzuriaga, K .
JOURNAL OF IMMUNOLOGY, 2001, 167 (08) :4450-4457
[8]
Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals [J].
Decker, LL ;
Klaman, LD ;
ThorleyLawson, DA .
JOURNAL OF VIROLOGY, 1996, 70 (05) :3286-3289
[9]
Long-term shedding of infectious Epstein-Barr virus after infectious mononucleosis [J].
Fafi-Kremer, S ;
Morand, P ;
Brion, JP ;
Pavese, P ;
Baccard, M ;
Germi, R ;
Genoulaz, O ;
Nicod, S ;
Jolivet, M ;
Ruigrok, RWH ;
Stahl, JP ;
Seigneurin, JM .
JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (06) :985-989
[10]
The curiously suspicious: a role for Epstein-Barr virus in lupus [J].
Harley, J. B. ;
Harley, I. T. W. ;
Guthridge, J. M. ;
James, J. A. .
LUPUS, 2006, 15 (11) :768-777